[1]
Natalya, E.G. 2018. Immune Biomarkers of Percutaneous Coronary Intervention Adverse Outcomes in Myocardial Infarction and Stable Angina Patients. Asian Journal of Pharmaceutics (AJP). 12, 03 (Nov. 2018). DOI:https://doi.org/10.22377/ajp.v12i03.2653.